Some of them were involved in modulation of hormonal messages (dopamine and serotonin receptor agonists and antagonists), selective estrogen receptor modulation (this category includes tamoxifen and raloxifene, widely used in breast cancer), and adrenergic receptor inhibition such as phentolamine. This evidence concerns the gene ESR1 and breast cancer.